Primary chemotherapy in breast cancer

Biomedicine and Pharmacotherapy

Volumn 52, Issue 3, 1998, Pages 116-121

  Smith, I E ^a   Al Moundhri, M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Primary chemotherapy; Prognostic factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; THIOTEPA; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; FOLLOW UP; HUMAN; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; TUMOR VOLUME;

EID: 0032055314     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(98)80089-9     Document Type: Article

References (25)

1. 1 Piccart MJ, Kerger J, Tomiak E. Systemic treatment for locally advanced breast cancer : what we still need to learn after a decade of multimodality clinical trials. Eur J Cancer 1992 ; 28 : 667-72
2. 2 Haagensen CD, Bodian C. A personal experience with Halsted's radical mastectomy. Ann Surg 1984 ; 199 : 143-50
3. 3 Forrest AP, Levack PA, Chetty U et al. A human tumour model. Lancet 1986 ; 2 : 840-2
4. 4 Anderson ED, Forrest AP, Hawkins RA et al. Primary systemic therapy for operable breast cancer. Br J Cancer 1991 ; 63 : 561-6
5. 5 Mansi J, Smith IE, Walsh G. Primary medical therapy for operable breast cancer. Eur J Cancer Clin Oncol 1989; 11 : 1623-7
6. 6 Bonadonna G, Valagussa P, Zucali R, Salvadori B. Primary chemotherapy in surgically resectable breast cancer. CA Cancer J Clin 1995 ; 45 : 227-43
7. 7 Jacquillat C, Weil M, Baillet F et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990 ; 66 : 119-29
8. 8 Chollet P, Belembaogo E, Cure H et al. Four year results of neoadjuvant chemotherapy for 148 operable breast cancer. Proc Annu Meet Am Soc Clin Oncol 1993 ; 12 : A157 (abst)
9. 9 Jones AL, Smith IE, O'Brien MER et al. Phase II study of continuous infusional 5-FU with epirubicin and cisplatin (infusional ECF) in patients with metastatic and locally advanced breast cancer : an active new regimen. J Clin Oncol 1994 ; 12 : 1259-65
10. 10 Smith IE, Walsh G, Jones A et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 1995 ; 13 : 424-9
11. 11 Fisher B, Brown A, Mamounas E et al. Effect of pre-operative chemotherapy on local-regional disease in women with operable breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B18. J Clin Oncol 1997 ; 17 : 2483-93
12. 12 Fisher B, Brown A, Mamounas E et al. Effect of pre-operative therapy for primary breast cancer on local-regional disease / disease-free survival and survival from NASBP B-18. Proc AM Soc Clin Oncol 1997 ; 16 : 449 (abstr)
13. 13 Powles TJ, Hickish TF, Makris A et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995 ; 13 : 547-52
14. 14 Mauriac L, Durand M, Avril A, Dilhuydy J-M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumours larger than 3 cm. Ann Oncol 1991 ; 2 : 347-54
15. 15 Scholl SM, Fourquet A, Asselain B et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors too large for breast conserving surgery : preliminary results of a randomized trial. Eur J Cancer 1994 ; 30A : 645-52
16. 16 Scholl SM, Asclain B, Beuzcboc P et al. Neo-adjuvant versus adjuvant chemotherapy in pre-menopausal patients with tumours considered too large for breast conserving surgery. An update (meeting abstract). Proc Annu Met Soc Clin Oncol 1995 ; 14: A200
17. 17 Semiglazov VF, Topuzov EE, Bavli JL et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994 ; 5/7 : 591-5
18. 18 Calais G, Berger C, Descamps P et al. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 1994 ; 74/4 : 1283-8
19. 19 Ellis P, Smith IE et al. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. J Clin Oncol 1998 ; 16 : 107-14
20. 20 Ferrière JP, Assier I, Cure H et al. Primary chemotherapy in breast cancer : correlation between tumour response and patient outcome. Proc Am Soc Clin Oncol 1996 ; 15 : 84 (abst)
21. 21 McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 1989 ; 124 : 21-5
22. 22 Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg 1995 ; 181/3 : 202-8
23. 23 Cameron DA, Anderson EDC, Levack et al. Primary systemic therapy for operable breast cancer - 10 year survival data after chemotherapy and hormonal therapy. Br J Cancer 1997 ; 76 : 1099-105
24. 24 Khayat D, Weil M, Auclerc G et al. Clinical relevance of tumor regression (TR) in neoadjuvant (neoadj) chemotherapy (chemo) in breast cancer (BC) revisited. Proc Annu Meet Am Soc Clin Oncol 1994 ; 13 : A99 (abst)
25. 25 Ellis PA, Smith IE, Salter J et al. Pre-operative chemotherapy for early breast cancer induces apoptosis. Lancet 1997 ; 349 : 849